Clene CLNN
NASDAQ CLNN
$3.88 +0.12 (+3.19%)
At close: Oct 22, 2026 · 4:00 PM EDT

Clene (CLNN) Return on Equity [ROE] (2021 - 2024)

Updated

Clene (CLNN) recorded Return on Equity [ROE] of -1738.36% in FY2024, down 1142.90 percentage points from -595.47% in FY2023.

Analysis

Clene (CLNN) Return on Equity [ROE] (2021 - 2024) Analysis & Trends

Starting with FY2021, Clene's Return on Equity [ROE] history includes 4 years.

  • Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -1587.80 percentage points (FY2021 to FY2024).
  • Per Business Quant data, CLNN's Return on Equity [ROE] was -595.47% in FY2023 (-217.57 pp), -377.90% in FY2022 (-227.33 pp) and -150.56% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 19.33%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 7.21%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 31.52%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 21.39%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 83.75%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -18.38%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 4.97%
10 Clene 49.58 Mn 19.51 Mn 54,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,620.00%
Mar 31, 2024 -553.01%
Dec 31, 2023 -284.59%
Sep 30, 2023 -188.16%
Jun 30, 2023 -491.91%
Mar 31, 2023 -3,521.94%
Jun 30, 2022 2,129.16%
Mar 31, 2022 228.03%
Dec 31, 2021 -106.55%
API Access

Clene Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLNN&period=max&api_key=YOUR_API_KEY